Nonadherence to medication four years after a first episode of psychosis and associated risk factors

Psychiatric Services

Volumn 61, Issue 2, 2010, Pages 189-192

  Hill, Michele ^a,c   Crumlish, Niall ^b,c   Whitty, Petter ^b,c   Clarke, Mary ^b,c   Browne, Stephen ^b,c   Kamali, Moayyad ^b,c   Kinsella, Anthony ^c,d   Waddington, John L ^c,e   Larkin, Conall ^b,c   O'Callaghan, Eadbhard ^c,d  

^a St John of God Services   (Ireland)

^b Stanley Research Unit   (Ireland)

^c Cluain Mhuire Family Centre   (Ireland)

^d DETECT   (Ireland)

^e ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE DURATION; DRUG MISUSE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HOSPITAL READMISSION; HUMAN; INTROSPECTION; IRELAND; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PROSPECTIVE STUDY; PSYCHOSIS; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT REFUSAL;

EID: 76049085765     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2010.61.2.189     Document Type: Article

References (15)

1. Gitlin M, Nuechterlein K, Subotnik KL, et al: Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. American Journal of Psychiatry 158:1835-1842, 2001
2. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002
3. Coldham EL, Addington J, Addington D: Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 106:286-290, 2002
4. Robinson DG, Woerner MG, Alvir JM, et al: Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research 57:209-219, 2002
5. Norman R, Malla A: Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis. Journal of Nervous and Mental Disease 190:331-334, 2002
6. Chow DHF, Law BTT: DUP and clinical outcome 1 year after FEP. Hong Kong Journal of Psychiatry 15:4-8, 2005
7. Clarke M, Whitty P, Browne S, et al: Untreated illness and outcome of psychosis. British Journal of Psychiatry 189:235-240, 2006
8. Adams SG, Howe JT: Predicting medication compliance in a psychotic population. Journal of Nervous and Mental Disease 181:558-560, 1993
9. Kamali M, Kelly BD, Clarke M, et al: A prospective evaluation of adherence to medication in first episode schizophrenia. European Psychiatry 21:29-33, 2006
10. Marshall M, Lewis S, Lockwood A, et al: Association between DUP and outcome in cohorts of first-episode patients. Archives of General Psychiatry 62:975-983, 2005
11. Norman R, Townsend L, Malla A: Duration of untreated psychosis and cognitive functioning in first-episode patients. British Journal of Psychiatry 179:340-345, 2001
12. Verdoux H, Lengronne J, Liraud F, et al: Medication adherence in psychosis: predictors and impact on outcome: a 2-year follow-up of first-admitted subjects. Acta Psychiatrica Scandinavica 102:203-210, 2000
13. Le Quach P, Mors O, Christensen T, et al: Predictors of poor adherence to medication among patients with first-episode schizophrenia-spectrum disorder. Early Intervention in Psychiatry 3:66-74, 2009
14. Velligan D, Lam Y, Glahn D, et al: Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophrenia Bulletin 32:724-742, 2006
15. Byerly M, Thompson A, Carmody T, et al: Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatric Services 58:844-847, 2007